Rong Tian

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Positron Emission Tomography

Neuroendocrine Tumors

Top Venues

Contrast media & molecular imaging

European radiology

Clinical nuclear medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zhou, Li Li, Hui Wang, He-Xiao Huang, Dan Cao, Neng-Wen Ke, Ming-Gang Su, Rong Tian
Heterogeneous Uptake of 68 Ga-DOTATATE and 18 F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients : Which Patients Are Suitable for Dual-Tracer PET Imaging? Clinical nuclear medicine 49 (6) (2024)
Hongxi Wang, Chao Zhang, Qianrui Li, Tian Tian, Rui Huang, Jiajun Qiu, Rong Tian
Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches. BMC cancer 24 (1) (2024)
Hongxi Wang, Chao Zhang, Qianrui Li, Tian Tian, Rui Huang, Jiajun Qiu, Rong Tian
Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches. BMC cancer 24 (1) (2024)
Yi Zhou, Li Li, Hui Wang, He-Xiao Huang, Dan Cao, Neng-Wen Ke, Ming-Gang Su, Rong Tian
Heterogeneous Uptake of 68Ga-DOTATATE and 18F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients: Which Patients Are Suitable for Dual-Tracer PET Imaging? Clinical nuclear medicine (2024)
Hongxi Wang, Qianrui Li, Tian Tian, Bin Liu, Rong Tian
Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer. The Journal of clinical endocrinology and metabolism (2024)
Hongxi Wang, Chao Zhang, Qianrui Li, Tian Tian, Rui Huang, Jiajun Qiu, Rong Tian
Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches. BMC cancer 24 (1) (2024)
Yuheng Zou, Mingxing Huang, Mingxing Hu, Hui Wang, Wei Chen, Rong Tian
Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer. Molecular pharmaceutics 21 (9) (2024)
Chong Jiang, Chunjun Qian, Zekun Jiang, Yue Teng, Ruihe Lai, Yiwen Sun, Xinye Ni, Chongyang Ding, Yuchao Xu, Rong Tian
Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study. European journal of nuclear medicine and molecular imaging (2023)
Qianrui Li, Wenxiu Hou, Ling Li, Minggang Su, Yan Ren, Wen Wang, Kang Zou, Rong Tian, Xin Sun
The use of systematic review evidence to support the development of guidelines for positron emission tomography: a cross-sectional survey. European radiology 31 (9) (2021)
Yi Zhou, Xue-Lei Ma, Ting Zhang, Jian Wang, Tao Zhang, Rong Tian
Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach. European journal of nuclear medicine and molecular imaging 48 (9) (2021)
Hongxi Wang, Shengnan Zhao, Li Li, Rong Tian
Development and validation of an 18F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma. European radiology 30 (10) (2020)
Yi Zhou, Xue-Lei Ma, Lu-Tong Pu, Ruo-Fan Zhou, Xue-Jin Ou, Rong Tian
Prediction of Overall Survival and Progression-Free Survival by the 18F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma. Contrast media & molecular imaging 2019 (2019)
Xuejin Ou, Jian Wang, Ruofan Zhou, Sha Zhu, Fuwen Pang, Yi Zhou, Rong Tian, Xue-Lei Ma
Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma. Contrast media & molecular imaging 2019 (2019)
Hongxi Wang, Guohua Shen, Chong Jiang, Li Li, Futao Cui, Rong Tian
Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis. PloS one 13 (3) (2018)